Verona Pharma Plc ADR
(VRNA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Sales | 40,000 | 0 | 0 | 0 | 0 |
| Gross Profit | 40,000 | N/A | N/A | N/A | N/A |
| Operating Expenses | 33,443 | 28,548 | 22,856 | 27,706 | 21,104 |
| Operating Income | 6,557 | -28,548 | -22,856 | -27,706 | -21,104 |
| Interest Expense | 86 | 85 | 84 | 0 | 0 |
| Other Income | 4,707 | 6,590 | 1,730 | 2,911 | 2,217 |
| Pre-tax Income | 11,178 | -22,043 | -21,210 | -24,795 | -18,887 |
| Income Tax | 127 | 25 | 80 | -256 | 44 |
| Net Income Continuous | 11,051 | -22,068 | -21,290 | -24,539 | -18,931 |
| Net Income | $11,051 | $-22,068 | $-21,290 | $-24,831 | $-18,931 |
| EPS Basic Total Ops | 0.16 | -0.40 | -0.40 | 0.02 | -0.44 |
| EPS Basic Continuous Ops | 0.19 | -0.38 | -0.36 | 0.08 | -0.44 |
| EPS Diluted Total Ops | 0.16 | -0.40 | -0.40 | 0.02 | -0.44 |
| EPS Diluted Continuous Ops | 0.19 | -0.38 | -0.36 | 0.08 | -0.44 |
| EBITDA(a) | $6,742 | $-28,346 | $-22,684 | $-27,545 | $-20,947 |